The inflammatory environment in the MDS bone marrow contains inflammation associated signaling molecules, such as the danger-associated molecular pattern (DAMP) heterodimer S100A8/S100A9 that will interact with its ligand CD33 on MDSCs. This evidence concerns the gene S100A9 and myelodysplastic syndrome.